Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04434378 · ClinicalTrials.gov registry record · Phase 4
Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair
A Phase 4 study, sponsored by Jewish Hospital, Cincinnati, Ohio.
- Terminated
- Registry status
- Phase 4
- Development phase
- 170
- Enrollment target
NCT04434378: Clinical Trial Phase 4 study, sponsored by Jewish Hospital, Cincinnati, Ohio.
NCT04434378 is a Phase 4 study that was terminated before completion, run by Jewish Hospital, Cincinnati, Ohio. The registered enrollment target is 170 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04434378, a Phase 4 study, was terminated before completion, sponsored by Jewish Hospital, Cincinnati, Ohio.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 170 participants
- Enrollment target
Study Summary
To investigate the effect of tamsulosin on the development of post-operative urinary retention (PUR) after elective laparoscopic inguinal hernia repair (LIHR). This will be accomplished by administering a pre-operative dose of tamsulosin. The primary outcome is the rate of urinary retention necessitating straight catheterization or insertion of foley catheter prior to discharge.
Primary Outcome
Patients undergoing laparoscopic inguinal hernia repair will be assessed for postoperative urinary retention in the post anesthesia care unit. Postoperative urinary retention will be tracked on the basis of urinary catheterization performed prior to hospital discharge. Criteria for catheterization include: i) Inability to urinate within 6 hours post-operatively, and bladder scan showing \>400 mL. ii) Inability to urinate at any time postoperatively with symptoms of urinary retention (i.e. urgenc
Interventions
- DRUG Placebo
- DRUG Tamsulosin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2017-11-16 |
| Est. Completion | 2020-02-05 |
| Phase | Phase 4 |
Why NCT04434378 stopped before completion
NCT04434378 is an interventional study that assigns participants to a tested intervention. The registered 170 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04434378 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04434378 about?
NCT04434378 is a clinical study titled "Tamsulosin to Prevent Postoperative Urinary Retention in Laparoscopic Inguinal Hernia Repair". To investigate the effect of tamsulosin on the development of post-operative urinary retention (PUR) after elective laparoscopic inguinal hernia repair (LIHR). This will be accomplished by administering a pre-operative dose of tamsulosin. The primary outcome is the rate of urinary retention necessit...
What is the current status of trial NCT04434378?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 170 participants. The study started on 2017-11-16. Estimated completion is 2020-02-05.
What interventions are being tested in trial NCT04434378?
The interventions under investigation include: Placebo (DRUG), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT04434378?
This trial is sponsored by Jewish Hospital, Cincinnati, Ohio, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04434378's enrollment target sits among peer trials
170 484th of 2000 higher than 1,514 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
- NCT04166409 · 170 participants · Phase 3
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI